Integral Health Asset Management, LLC Avalo Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$3.0 - $10.45 $2.1 Million - $7.31 Million	-700,000 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$7.57 - $21.72 $7 Million - $20.1 Million	-925,000 Reduced 56.92%	700,000 $507,000
Q3 2021 Nov 12, 2021	BUY	$26.16 - $40.68 $42.5 Million - $66.1 Million	1,625,000 New	1,625,000 $3.54 Million

34.6K

Ticker AVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,414,100
Market Cap $105M
Description
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.